U.S. Department of Health & Human Services
Featured News
Image
Featured News
Emergency department-administered, high-dose buprenorphine may enhance opioid use disorder treatment outcomes
July 15, 2021
High-dose buprenorphine therapy, provided under emergency department care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a study supported by the National Institutes of Health’s National Institute on Drug Abuse (NIDA) through the Helping to End Addiction Long-term Initiative, or the NIH HEAL Initiative.
Read the press releaseLatest Research Spotlight
Image
Latest Research Spotlight
ACTing Now to Help Infants Across America
Testing new approaches to treat babies born in opioid withdrawal
Read the SpotlightFeatured Video
Emotional Well-Being and the Power of Connections to Fight the Opioid Epidemic
NIH Director Dr. Francis Collins and U.S. Surgeon General Dr. Vivek Murthy discuss how chronic stress and isolation have profound implications for health, productivity and happiness, and how love, compassion, and kindness show us the way forward.Research Spotlights
Read in-depth stories about research projects supported by the initiative.